As per the announcement, BlackBerry has collaborated with technology firm ONEBIO to develop a blockchain-powered ‘ultra-secure’ ecosystem. The system is intended for storage and sharing of medical data, where the data can be entered by laboratories, patients and Internet of Things (IoT) biometric devices. Once entered, information will further be anonymized and shared with researchers.
CEO of BlackBerry Mr. John Chen stated:
“We are implementing our expertise in security, communication, and, data privacy work in regulated industries such as automotive, financial services, and government to tackle one of the biggest challenges in the healthcare industry: leveraging healthcare endpoints to improve patient outcomes while assuring security and data privacy.”
Amidst other products, BlackBerry has further presented a real-time operating system for the development of a patient monitoring system, robotic surgical instruments, and other safety-critical products that must pass regulatory approvals.
At one time BlackBerry controlled 50% of the global smartphone market, in 2016 the firm controlled less than 0.1%. Meanwhile, BlackBerry is still in the smartphone business and will launch its latest smartphone on 10th October – the recent blockchain initiative is indicative of the companies move into other fields.
Today, BlackBerry further announced a new quantum-resistance code signing services that will ‘enable software to be digitally signed applying a scheme that will be tough to break with a quantum computer.’